Large-scale testing (Phase 3)Study completedNCT02964936
What this trial is testing
Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
Who this might be right for
Chronic Kidney Disease
Astellas Pharma Inc 100